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Abstract
Objective—To estimate utilization rates for cystometrograms and describe trends in urodynamic 
procedures among U.S. women from 2000 to 2012.
Methods—We analyzed outpatient administrative healthcare claims for women aged 18 years or 
older from 2000–2012. The database contains de-identified and adjudicated claims from 
approximately 150 U.S. payers for employees, spouses, and retirees. We identified 
cystometrograms, which occur during bladder filling and represent a major component of complex 
urodynamics, and concurrent procedures; we also assessed age, year, region, provider specialty, 
and associated diagnosis codes. We estimated standardized cystometrogram utilization rates per 
10,000 person-years and 95% confidence intervals (CI), and used stratified Poisson models to 
estimate the independent (adjusted) effects of year and region.
Results—During 142,928,847 person-years of observation among 57,629,961 eligible women, 
we identified 561,823 cystometrograms for an overall utilization rate of 39.3 per 10,000 person-
years (95%CI 39.2–39.4). Cystometrogram utilization increased with age, with a peak at age 76 
(86.6 per 10,000 person-years, 95%CI 84.5–88.7). Standardized rates were relatively constant 
from 2000 to 2004, then increased and peaked in 2009 (43.3 per 10,000 person-years, 95%CI 
43.0–43.7). In 2012, they were substantially lower (27.6 per 10,000 person-years, 95%CI 27.4–
27.9).
Conclusion—Urodynamic procedures were more commonly performed in women aged 65 years 
or older. Utilization peaked in 2009 and declined sharply in 2012. Clinically, we need to assess the 
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underlying reasons for these trends (ie whether they reflect a decrease in urodynamics prior to 
stress incontinence surgery), and whether these trends reflect appropriate use of this diagnostic 
study.
INTRODUCTION
Urodynamic studies are commonly performed procedure in women for the evaluation of 
urinary incontinence and voiding dysfunction.(1–3) While urodynamic studies may assist in 
the evaluation of a patient with incontinence or voiding dysfunction, these costly procedures 
may be associated with an increased risk of UTI and discomfort.(4–6) Complex urodynamic 
investigations can include several components, such as uroflowmetry, cystometrograms, 
urethral pressure profile, and a voiding pressure study. Cystometrograms represent a major 
component of urodynamic procedures, as they are performed during bladder filling and can 
evaluate bladder sensation, bladder capacity, compliance, detrusor function, urodynamic 
stress incontinences and urethral function; thus, we considered this procedure to be broadly 
representative of urodynamics utilization.(1)
Currently, limited data exist regarding the trends and patterns of urodynamic procedures in 
the United States. It is important to evaluate this information given 1) recent studies in 
2012(7) and 2013(8) have shown that preoperative urodynamic testing may not be needed 
for uncomplicated stress incontinence, 2) current procedural terminology (CPT) coding 
changes in 2010 decreased reimbursement which could potentially lead to a decline in 
utilization(9), and 3) the overall healthcare economic implications of these costly 
procedures. Given the need to evaluate trends in urodynamic procedures and the limitations 
in the existing literature, we sought to estimate the utilization rates for cystometrograms (i.e. 
the number of cystometrograms performed per 10,000 person-years experienced by the 
eligible population) and to describe trends in urodynamic procedures among U.S. adult 
women from 2000 to 2012.
MATERIALS AND METHODS
We conducted analyses using 13 years (2000–2012) of outpatient administrative health 
claims from the MarketScan database which includes de-identified and adjudicated 
healthcare claims from approximately 150 payers in the U.S. for employees, their spouses, 
dependents and retirees. Outpatient claims include encounters at outpatient doctor’s offices, 
ambulatory surgical centers, emergency rooms, and outpatient hospital facilities. The 
database includes the Commercial Claims & Encounters database, which is comprised of 
large employer-provided insurance plans for individuals under 65, and Medicare 
Supplemental database, which is comprised of employer-supplemented Medicare plans for 
individuals 65 or older.(10,11) Claims and enrollment data have been validated to ensure 
completeness, accuracy, and reliability.(12) In 2011, this database included approximately 
53 million individuals. For context, 55.1% of the U.S. population in 2011, or 170.1 million 
individuals, had employment-based insurance; thus, this database includes a significant 
proportion of those with employer-based insurance.(13) Because few urodynamic 
procedures occur in the inpatient setting, inpatient medical claims were not included in the 
analysis.
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The study population included all women aged 18 years or older. We identified index 
cystometrograms, which were considered the primary urodynamic procedure, based on 
Current Procedural Terminology (CPT) codes [51725, 51726, 51727, 51728, 51729]. We 
treated cystometrograms as the primary urodynamic procedure for two reasons: 1) we were 
interested in complex urodynamic investigations which nearly always include a 
cystometrogram(1) and 2) this was the approach taken by Reynolds et al. thereby allowing 
for comparison of our results.(14,15) We identified claims for additional urodynamic 
procedures performed on the same service date as the index cystometrogram, including 
uroflowmetry [51741], urethral pressure profiles [51772, 51727, 51729], voiding pressure 
studies [51795, 51797, 51728, 51729], electromyography [51784, 51785], and fluoroscopy/
video-urodynamics [74430, 74450, 74455, 76000, 76001]. New CPT codes for urodynamic 
procedures were implemented in January 1, 2010 to allow for the bundling of payments for 
cystometrograms, voiding pressure studies, and urethral pressure profiles performed 
concomitantly (e.g. cystometrogram + voiding pressure study or cystometrogram + voiding 
pressure study + urethral pressure profile). To address this change in policy, bundled CPT 
codes were added to definitions of cystometrograms, voiding pressure studies, and urethral 
pressure profiles starting in 2010.
We evaluated patient age, calendar year, and region of service (i.e. Northeast, North Central, 
South, West, unknown). We also considered provider specialty and diagnoses associated 
with the index cystometrogram procedure (International Classification of Diseases, Ninth 
Revision, Clinical Modification [ICD-9-CM]). We assessed the diagnoses associated with 
cystometrograms by inspecting all ICD-9 diagnosis codes recorded with the urodynamic 
procedures. We collapsed the 30 most frequent diagnosis codes into 19 categories. For each 
cystometrogram, we determined provider type based on the specialty of the billing 
physician.
In order to estimate utilization rates for cystometrogram procedures, we divided the number 
of cystometrograms by the total enrolled person-time accrued by urodynamics-eligible 
women. We estimated cystometrogram utilization rates within strata of age, calendar year, 
and region of service, dividing the frequency of cystometrograms by the total person-time in 
each stratum.(16) While we considered cystometrograms to be representative of 
urodynamics use as a whole, we also estimated the proportion of cystometrograms 
accompanied by uroflowmetry, voiding pressure studies, urethral pressure profiles, 
electromyography, and fluoroscopy. We assumed procedures were concomitant to the index 
cystometrogram only if they were performed on the same date of service. In order to 
describe temporal changes in the type/complexity of urodynamic studies being used, we 
evaluated these proportions across different calendar years.
In order to observe trends in utilization by region and calendar year that were not 
confounded by changes in the age or regional representation of the study database over time, 
we estimated standardized utilization rates and 95% confidence intervals (CI). Calendar year 
utilization rates were standardized by age and region while regional utilization rates were 
standardized by age and calendar year. Standardized utilization rates were calculated by 
reweighting the data in each year/region such that the distribution of person-time in all 
years/regions resembled the same standard population.(17) This standard population was 
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defined using the 2010 Current Population Survey (CPS) and included U.S. women younger 
than 65 with employer-provided health plans and U.S. women 65 years and older with 
employer-supplemented Medicare plans, as estimated by the 2010 Current Population 
Survey (CPS).(18)
We used Poisson regression to estimate utilization rate ratios and 95% CI adjusted by age 
and calendar year for regional comparisons and adjusted by age and region for calendar year 
comparisons. We also stratified the models by age (<65 and ≥65) and used Wald chi-square 
statistics to evaluate whether each individual year 2005 to 2012 was significantly different 
from a referent period of 2000 to 2004.
This study was reviewed by University of North Carolina’s institutional review board (study 
#: 10-0153) and found to be exempt. All analyses were conducted with SAS 9.3 (SAS 
Institute, Cary, NC).
RESULTS
Among 57,629,961 eligible women in the database contributing an average of 2.48 person-
years each, we observed 142,928,847 total person-years of eligibility. We identified 561,823 
cystometrograms (493,956 unique patients) for an overall utilization rate of 39.3 per 10,000 
person-years (95% CI 39.2–39.4). The size of the study cohort increased substantially over 
time (as Truven Health Analytics expanded the number of employer-based health plans that 
it aggregated), accruing 1,583,535 person-years in 2000 and 19,597,100 person-years in 
2012. Table 1 presents the total person-time and cystometrogram procedure frequencies 
observed in each category of age, calendar year, and region of service.
Cystometrogram utilization rates had a minor peak in the crude rate at age 50 (49.0 per 
10,000 person-years, 95% CI 48.3–49.8) and a major peak at age 76 (86.6 per 10,000 
person-years, 95% CI 84.5–88.7). The standardized cystometrogram utilization rate, which 
was relatively constant in the period 2000 to 2004, increased until 2009 and remained 
elevated in 2011 before decreasing in 2012 (Table 2). Figure 1 displays age-specific 
standardized cystometrogram utilization rates by calendar time. The rate peaked in 2009 
(43.3 per 10,000 person-years, 95% CI 43.0–43.7), and was lowest after the sharp decline in 
2012 (27.6 per 10,000 person-years, 95% CI 27.4–27.9). While the age-adjusted 
cystometrogram utilization rate was highest in the South (40.2 per 10,000 person-years, 95% 
CI 39.9–40.4), we observed similar rates in the North Central, and Northeast (Table 2). The 
West, however, had a lower rate (27.6 per 10,000 person-years, 95% CI 27.2–27.9) than the 
other regions. Figure 2 displays age-specific standardized cystometrogram utilization rates 
by region.
Compared to 2000–2004, the age-adjusted cystometrogram utilization rate was significantly 
higher in each year from 2005 through 2012 among patients 65 years and older. Among 
patients under age 65, the rate in 2012 was lower than in 2000–2004 (Table 2). Among all 
patients, utilization was similar in the South, North Central, and Northeast, but lower in the 
West. Decreased utilization in the West was more pronounced among patients under 65 
(0.66, 95% CI 0.65–0.67) than among patients 65 and older (0.77, 95% CI 0.75–0.78).
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Voiding pressure studies were performed concomitantly with 81.0% of cystometrograms, 
uroflowmetry with 73.0%, electromyography with 56.7%, urethral pressure profiles with 
54.9%, and fluoroscopy with 5.2% (Table 3). Evaluating the change in these proportions 
over the study period yielded an absolute increase of at least 30% for voiding pressure 
studies, uroflowmetry, electromyography, and urethral pressure profiles (Figure 3). The 
proportion of cystometrograms accompanied by fluoroscopy procedures fell steadily over 
the study period from 7.6% in 2000 to 5.1% in 2012. The most frequent diagnoses 
accompanying cystometrograms were stress urinary incontinence (39.0%), frequency/
urgency/nocturia (16.1%), mixed incontinence (13.5%), unspecified urinary incontinence 
(10.4%), and urge urinary incontinence (10.1%), which account for 39.0%, 16.1%, 13.5%, 
10.4%, 10.1% of cystometrograms ordered, respectively (Table 3). Most cystometrograms 
performed on female patients were billed by either urologists (39.0%) or obstetrician–
gynecologists (36.6%) (Table 3).
DISCUSSION
Our utilization rate estimates provide important insight into the patterns of urodynamic 
testing in U.S. women. Our study provides novel age-specific rates which show that the rates 
of urodynamic studies increased with age and that these procedures are commonly 
performed in women over 65 years of age (Table 2, Figure 1). Utilization rates increased 
from 2011 and then declined sharply in 2012. Additionally, over the last decade, these 
studies have become more complex, as cystometrograms were more commonly 
accompanied by uroflowmetry, urethral pressure profiles, voiding pressure studies and 
electromyography in 2012 compared to 2000 (Figure 3).
When trying to understand these trends, there are a number of different factors to consider. 
One influence may be the growing number of providers trained to perform complex 
urodynamic procedures in women. The decrease in the 2012 rate could reflect practice 
patterns for not conducting preoperative urodynamics before stress incontinence surgery, a 
practice which has been substantiated by recent trials.(7,8). CPT coding changes in 2010 
decreased reimbursement, which may have influenced rates.(9) Another factor may be that 
fewer midurethral mesh slings were performed after the FDA safety notifications,(19) which 
reduced the need for preoperative urodynamic procedures. The clinical implications of our 
results are that we need to continue to assess the indications for urodynamic testing, the 
underlying reasons for changes in trends over time, and whether these trends reflect 
appropriate use, or over- or under-utilization of this diagnostic study.
Prior studies on trends in urodynamics did not provide data from 2010–2012, which is 
important to assess given changes in CPT codes for these procedures.(14,15,20) A prior 
analysis conducted on a combined male and female cohort evaluated commercial healthcare 
claims for urodynamics from 2002–2007, but did not estimate utilization rates or trends over 
calendar time.(15)
Reynolds et al.(14) validly assessed utilization from 2000–2009; however, they failed to 
capture codes for cystometrograms bundled with voiding pressure studies or urethral 
pressure profiles that were introduced in 2010. Furthermore, they did not control for 
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differences in age distributions when comparing utilization by calendar year, region, race, 
and urban/rural status, which may explain differences between our results. We felt that 
standardization was necessary, given the potential for differences in age profiles over the 13 
calendar years being compared and in the different regions to confound the interpretation of 
trends.
While our study found similar patterns-of-use in older patients groups to the Reynolds et al.
(14) study on Medicare beneficiaries (i.e. peak rates among women 75–79, decrease in those 
80–84, sharp decline in women >84), our cystometrogram rates were substantially higher, 
which may be driven by a number of factors. First, Reynolds et al. calculated a one-year 
incidence proportion (per person), while we calculated an incidence rate (per person-year). 
Second, our study population ≥65 (i.e. women with employer-supplemented Medicare 
coverage) may actually utilize more urodynamic procedures than the general Medicare fee-
for-service population evaluated by Reynolds.
This study has a number of limitations. First, given that our healthcare claims data did not 
include specific patient-level information regarding indications for the procedures or the 
results, we are unable to comment on the appropriateness of increasing or decreasing rates. 
Second, comparisons and trends may be confounded by unmeasured variables not routinely 
available in claims data (e.g. race/ethnicity, BMI). Third, this study population represents 
women with employer based insurance and thus our results may not be generalizable to 
Medicaid enrollees, underinsured individuals, or the uninsured. Lastly, while expect false or 
missing claims to be rare for urodynamic procedures, actual utilization rates may be slightly 
higher or lower than those estimated.
The strengths of our study include that we used a large population-based cohort which 
includes recent years of data that have not been captured in the existing literature, with 
claims for both older (≥65) and younger (<65) patients. The sample of cystometrograms 
studied is eight times larger than the next largest study(14), which allowed for the 
calculation of precise utilization rate estimates and detailed analysis age-specific trends by 
calendar year. We also focused exclusively on women, providing unique insights into trends 
in women which may be quite different from those in men. Finally, we used Poisson models 
and standardization methods to enable the evaluation of independent effects of calendar year 
and region.
In conclusion, urodynamic investigations were most common in women older than 65 and 
increased in use and complexity over the last decade. These trends have important 
healthcare cost implications given the increasing expenditures from these urodynamic 
studies. Future research will be needed to assess the appropriateness of urodynamic testing 
and if the declining utilization of urodynamic procedures continues in subsequent years.
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Age-specific cystometrogram utilization rates per 10,000 person-years by calendar year, 
U.S. women 2000–2012. Age-specific rates within each calendar year time period have been 
standardized by region using the regional distribution observed in the 2010 Current 
Population Survey.
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Age-specific cystometrogram utilization rates per 10,000 person-years by region, U.S. 
women 2000–2012. Age-specific rates within each region have been standardized by 
calendar year, assuming equal representation from each year of data (2000–2012).
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Proportion of cystometrograms accompanied by voiding pressure studies, urethral pressure 
profiles, electromyography, and fluoroscopy procedures by calendar year, U.S. women 
2000–2012.
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Table 1
Observed person-time and cystometrogram procedure frequencies by age, calendar year, and region of service, 
for U.S. women, 2000–2012.
Person-years n
Age
 18–24 15,665,026 6,181
 25–29 10,385,911 8,362
 30–34 11,947,530 18,325
 35–39 13,189,724 36,449
 40–44 14,645,040 57,690
 45–49 15,983,160 75,879
 50–54 16,188,969 78,706
 55–59 14,842,490 74,857
 60–64 11,875,626 70,756
 65–69 4,963,459 37,599
 70–74 4,141,817 34,709
 75–79 3,614,829 30,406
 80–84 2,867,981 20,382
 85+ 2,617,286 11,522
Year
 2000 1,583,535 5,569
 2001 2,608,311 9,316
 2002 4,483,152 15,411
 2003 6,901,888 22,079
 2004 8,989,072 31,387
 2005 9,899,448 38,653
 2006 10,553,919 43,514
 2007 10,607,102 45,347
 2008 15,583,619 68,068
 2009 15,551,472 71,346
 2010 16,946,406 74,397
 2011 19,623,824 81,897
 2012 19,597,100 54,839
Region
 South 58,041,737 238,135
 North Central 36,357,369 154,459
 West 27,448,395 80,135
 Northeast 19,442,855 82,214
 Unknown 1,638,491 6,880
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Table 3
Counts by procedure type, associated diagnosis, and provider specialty and the proportion of cystometrograms 
represented by each, for U.S. women, 2000–2012.
n CMGs (%)
Procedures Accompanying cystometrograms1,2
 Cystometrogram 561,823 100
  + Voiding pressure study 454,919 81.0
  + Uroflowmetry 409,997 73.0
  + Electromyography 318,301 56.7
  + Urethral pressure profile 308,349 54.9
  + Fluoroscopy 29,214 5.2
Diagnosis2,3.4
 Stress urinary incontinence 219,153 39.0
 Frequency/urgency/nocturia 90,208 16.1
 Mixed incontinence 76,019 13.5
 Unspecified urinary incontinence 58,408 10.4
 Urge urinary incontinence 56,805 10.1
 Incomplete emptying/obstruction/retention 43,702 7.8
 Cystocele 29,694 5.3
 Urinary tract infection/cystitis 19,018 3.4
 Hypertonicity of bladder 15,927 2.8
 Other functional disorder of bladder 15,364 2.7
 Neurogenic bladder 12,727 2.3
Provider Specialty5
 Urology 213,398 38.0
 Obstetrics & gynecology 205,575 36.6
 Medical doctor 60,863 10.8
 Multi-specialty physician group 18,098 3.2
 Other 17,512 3.1
 Missing 46,377 8.3
1
“CMGs (%)” refers to the proportion of cystometrogram service encounters that were accompanied by each procedure (on the same day). For 
example, 81.0% of cystometrograms were performed concomitantly with voiding pressure studies.
2
Since a single cystometrogram can be accompanied by multiple procedures or multiple diagnosis codes, summing the “CMGs (%)” column across 
these variables yields a value greater than 100%
3
Diagnosis counts are based on any diagnosis associated with any of the procedures ordered on a single service day for a given enrollee, not just 
the cystometrogram. Diagnoses that were coded for multiple procedures on the same day were not double counted. “CMGs (%)” refers to the 
proportion of cystometrogram service encounters that contained each diagnosis code. For example, 39.0% of cystometrograms ordered for women 
were associated with a code for stress urinary incontinence.
4
We used ICD-9 diagnosis codes to define the diagnosis categories as follows: stress urinary incontinence (625.6), frequency/urgency/nocturia 
(788.41, 788.43, 788.63), mixed incontinence (788.33), unspecified urinary incontinence (788.3), urge urinary incontinence (788.31), incomplete 
emptying/slow stream/retention (788.20, 788.21, 788.62), cystocele (618.0, 618.01, 618.02), urinary tract infection/cystitis (599.0, 595.1, 595.2), 
hypertonicity of bladder (596.51), other functional disorder of bladder (596.59), neurogenic bladder (596.54).
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5
Provider specialty counts reflect the provider that billed the index cystometrograms, not necessarily providers that billed other urodynamic exams. 
“CMGs (%)” refers to the proportion of cystometrograms billed by each specialty.
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